These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23822740)

  • 1. Clinicopathological significance of claudin-4 in gastric carcinoma.
    Zhu JL; Gao P; Wang ZN; Song YX; Li AL; Xu YY; Wang MX; Xu HM
    World J Surg Oncol; 2013 Jul; 11():150. PubMed ID: 23822740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of claudin-2 in the multistage process of gastric carcinogenesis.
    Song X; Li X; Tang Y; Chen H; Wong B; Wang J; Chen M
    Histol Histopathol; 2008 Jun; 23(6):673-82. PubMed ID: 18366005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival.
    Ohtani S; Terashima M; Satoh J; Soeta N; Saze Z; Kashimura S; Ohsuka F; Hoshino Y; Kogure M; Gotoh M
    Gastric Cancer; 2009; 12(1):43-51. PubMed ID: 19390931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma.
    Hu X; Xin Y; Xiao Y; Zhao J
    Pathol Oncol Res; 2014 Oct; 20(4):805-11. PubMed ID: 24643316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance.
    Kapranos N; Kominea A; Konstantinopoulos PA; Savva S; Artelaris S; Vandoros G; Sotiropoulou-Bonikou G; Papavassiliou AG
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):426-32. PubMed ID: 12200599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions.
    Cunningham SC; Kamangar F; Kim MP; Hammoud S; Haque R; Iacobuzio-Donahue CA; Maitra A; Ashfaq R; Hustinx S; Heitmiller RE; Choti MA; Lillemoe KD; Cameron JL; Yeo CJ; Schulick RD; Montgomery E
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):281-7. PubMed ID: 16492916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
    Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
    World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.
    Luo D; Huang H; Lu ML; Zhao GF; Chang J; Zheng MY; Wang Y
    Pathol Oncol Res; 2012 Apr; 18(2):491-7. PubMed ID: 22109561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of Claudin-4 in gastric cancer tissue: A single center experience.
    Moris D; Schizas D; Michalinos A; Kanavidis P; Dimitrokallis N; Alexandrou A; Misiakos E; Liakakos T
    J BUON; 2017; 22(2):403-409. PubMed ID: 28534362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tight junction protein claudin 4 in gastric carcinoma and its relation to lymphangiogenic activity.
    Shareef MM; Radi DM; Eid AM
    Arab J Gastroenterol; 2015; 16(3-4):105-12. PubMed ID: 26526513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of claudin-18 is associated with the proliferative and invasive potential of gastric cancer at the invasive front.
    Oshima T; Shan J; Okugawa T; Chen X; Hori K; Tomita T; Fukui H; Watari J; Miwa H
    PLoS One; 2013; 8(9):e74757. PubMed ID: 24073219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
    Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
    Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
    Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a LINE-1 endonuclease variant in gastric cancer: its association with clinicopathological parameters.
    Wang G; Gao J; Huang H; Tian Y; Xue L; Wang W; You W; Lian H; Duan X; Wu B; Wang M
    BMC Cancer; 2013 May; 13():265. PubMed ID: 23718141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
    Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
    Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
    Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
    Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.
    Xu XY; Gou WF; Yang X; Wang GL; Takahashi H; Yu M; Mao XY; Takano Y; Zheng HC
    Tumour Biol; 2012 Dec; 33(6):1845-54. PubMed ID: 22948776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
    Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
    World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma.
    Jin J; Jin T; Quan M; Piao Y; Lin Z
    Diagn Pathol; 2012 Oct; 7():135. PubMed ID: 23039327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma.
    Satake S; Semba S; Matsuda Y; Usami Y; Chiba H; Sawada N; Kasuga M; Yokozaki H
    Pathol Int; 2008 Mar; 58(3):156-63. PubMed ID: 18251778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.